For the two clinical groups, participants are recruited from patients in psychiatric wards and outpatient psychiatric services.
Conditions
Interventions
Group 1: Group 1 (inpatient group): The psychiatric inpatients will complete the OPD-SQS, OPD-CQ, as well as other questionnaires for construct validation (BSI (Brief Symptom Inventory)
BFI-10 (Big Five Inventory-10)
IPO-20 (Inventory of Personality Organization-20)
LPFS-BF (Level of Personality Functioning Scale - Brief Form)
ECR-R (Experiences in Close Relationships - Revised)
RSES (Rosenberg Self-Esteem Scale)) one time.
Group 2: Group 2 (outpatient group): The outpatients from psychiatric services will complete the same questionnaires as the outpatient clinical group (OPD
BSI (Brief Symptom Inventory)
RSES (Rosenberg Self-Esteem Scale)) one time.
Group 3: Group 3 (non-clinical): The non-clinical participants will complete the OPD-SQS (questionnaire on psychic structure or personality functioning) a
RSES (Rosenberg Self-Esteem Scale)) a first time, and both OPD questionnaires again one month later in order to assess test-retest reliability.
Sponsors
Centre Hospitalier Universitaire Vaudois (CHUV)
Hôpitaux universitaires de Genève (HUG)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Non-clinical group: - Informed consent to participate in the study. Clinical groups: - Informed consent to participate in the study; - Outpatient or hospital consultation in a psychiatric department for psychological distress/mental disorder.
Exclusion criteria
Exclusion criteria: Non-clinical group: - Current psychological or psychiatric treatment; - Intention to start psychotherapy in the near future; - Not wanting to be informed in the event of an incidental discovery of significant level of psychological distress - BSI T Score = 63 Clinical groups: - Cognitive deficit that may compromise understanding of questionnaire questions; - Insufficient knowledge of French (unable to read and understand the questions); - Excessive agitation; - Impaired capacity for autonomous decision-making in medical care (based on clinical evaluation)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Internal validity, convergent validity and structural validity; and reliability (internal consistency, test-retest) | — |
Secondary
| Measure | Time frame |
|---|---|
| Convergent and discriminant validity with other scales that have already been validated and are currently used in clinical and research settings. Estimation of the test-retest reliability of the non-clinical group. Identification of a difference between the scores of a clinical and a non-clinical sample | — |
Countries
Switzerland
Contacts
Public ContactGilles Ambresin
Centre Hospitalier Universitaire Vaudois (CHUV)
Outcome results
None listed